Newsfeeds - Spark Newswire

3 minute read

Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About

Today, 8:33 PM

Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. Retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.

BBBY

1 minute read

Movers

Why Is Reata Pharmaceuticals Stock Trading Higher Today?

By Ye Kuang

Today, 8:33 PM

Reata Pharmaceuticals (NASDAQ: RETA) shares are trading higher on Wednesday after the company announced the FDA approved SKYCLARYS for the treatment of Friedreich's ataxia.

RETA

3 minute read

Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 8:33 PM

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

ADMP

3 minute read

Dow Edges Higher; ISM Manufacturing PMI Rises In February

By Lisa Levin

Today, 8:33 PM

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 30 points on Wednesday. The Dow traded up 0.12% to 32,695.97 while the NASDAQ fell 0.23% to 11,429.16. The S&P 500 also fell, dropping, 0.17% to 3,963.32.

AMPY

2 minute read

3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday

By Lisa Levin

Today, 8:33 PM

U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session.

AMPH

1 minute read

Why Reata Pharma Shares Are Skyrocketing Today

By Vandana Singh

Today, 8:33 PM

The FDA approved Reata Pharmaceuticals Inc’s (NASDAQ:RETA) Skyclarys (omaveloxolone) for Friedreich’s ataxia in adults and adolescents aged 16 and older. With…

RETA

2 minute read

Reata Pharmaceuticals Unusual Options Activity For February 27

By Benzinga Insights

Today, 8:33 PM

A whale with a lot of money to spend has taken a noticeably bearish stance on Reata Pharmaceuticals. Looking at options history for Reata Pharmaceuticals (NASDAQ:RETA) we detected 22 strange trades.

RETA

4 minute read

Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 8:33 PM

Gainers Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test.

AAMC